Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients

NCT03870919 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNICANCER

Collaborators